Prime medicine to present at virtual investor conferences in may

Cambridge, mass., may 17, 2023 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that keith gottesdiener, m.d., president and chief executive officer of prime medicine, will present at two virtual investor conferences in may:

PRME Ratings Summary

PRME Quant Ranking